PharmAust (ASX:PAA) Other Operating Expense : A$0.24 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PharmAust Other Operating Expense?

PharmAust's Other Operating Expense for the six months ended in Dec. 2023 was A$-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.24 Mil.

PharmAust's quarterly Other Operating Expense increased from Dec. 2022 (A$0.16 Mil) to Jun. 2023 (A$0.24 Mil) but then declined from Jun. 2023 (A$0.24 Mil) to Dec. 2023 (A$-0.00 Mil).

PharmAust's annual Other Operating Expense increased from Jun. 2021 (A$0.30 Mil) to Jun. 2022 (A$0.32 Mil) and increased from Jun. 2022 (A$0.32 Mil) to Jun. 2023 (A$0.40 Mil).

PharmAust Other Operating Expense Historical Data

The historical data trend for PharmAust's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmAust Other Operating Expense Chart

PharmAust Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Operating Expense

Get a 7-Day Free Trial

0.17

0.28

0.30

0.32

0.40

PharmAust Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															0.17	0.15	0.16	0.24	-

PharmAust Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.24 Mil.

PharmAust Other Operating Expense Related Terms

Thank you for viewing the detailed overview of PharmAust's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmAust (ASX:PAA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmAust Ltd (ASX:PAA) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

ECQ:Germany ECQ:Germany

Address

1 Kyle Way, Suite 116, Claremont, Perth, WA, AUS, 6010

Website

https://www.pharmaust.com

PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.